Assessment of arterial hypervascularity of hepatocellular carcinoma: Comparison of contrast-enhanced US and gadoxetate disodium-enhanced MR imaging

European Radiology

Volumn 22, Issue 6, 2012, Pages 1205-1213

  Sugimoto, Katsutoshi ^a   Moriyasu, Fuminori ^a   Shiraishi, Junji ^b   Saito, Kazuhiro ^a   Taira, Junichi ^a   Saguchi, Toru ^a   Imai, Yasuharu ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Contrast media; Gadoxetic acid; Hepatocellular carcinoma; MRimaging; Ultrasound

Indexed keywords

GADOXETIC ACID;

AGED; AREA UNDER THE CURVE; ARTERIAL HYPERVASCULARITY; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CT DURING HEPATIC ARTERIOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LIVER ARTERIOGRAPHY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOLOGIST; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; VASCULARIZATION;

AGED; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; NEOVASCULARIZATION, PATHOLOGIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY;

EID: 84861490285     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-011-2372-3     Document Type: Article

References (31)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108 (Pubitemid 40372904)
2. Bruix J, ShermanM(2005) Management of hepatocellular carcinoma. Hepatology 42:208-1236
3. Bruix J, ShermanM(2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020-1022
4. Hamm B, Staks T, Mühler A et al (1995) Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 195:785-792
5. Reimer P, Rummeny EJ, Shamsi K et al (1996) Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 199:177-183 (Pubitemid 26098637)
6. Vogl TJ, Kümmel S, Hammerstingl R et al (1996) Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 200:59-67 (Pubitemid 26197732)
7. Huppertz A, Balzer T, Blakeborough A et al (2004) Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 230:266-275 (Pubitemid 37549812)
8. Bluemke DA, Sahani D, Amendola M et al (2005) Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology 237:89-98 (Pubitemid 41346150)
9. Huppertz A, Haraida S, Kraus A et al (2005) Enhancement of focal liver lesions at gadoxetic acid-enhancedMRimaging: correlation with histopathologic findings and spiral CT-initial observations. Radiology 234:468-478 (Pubitemid 40139918)
10. Halavaara J, Breuer J, Ayuso C et al (2006) Liver tumor characterization: comparison between liver-specific gadoxetic acid disodiumenhancedMRI and biphasic CT - a multicenter trial. J Comput Assist Tomogr 30:345-354 (Pubitemid 43922248)
11. Kim SH, Kim SH, Lee J et al (2009) Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 192:1675-1681
12. Jung G, Breuer J, Poll LW et al (2006) Imaging characteristics of hepatocellular carcinoma using the hepatobiliary contrast agent Gd-EOB-DTPA. Acta Radiol 47:15-23 (Pubitemid 43177525)
13. Ichikawa T, Saito K, Yoshioka N et al (2010) Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Invest Radiol 45:133-141
14. Xu HX, Xie XY, Lu MD et al (2008) Contrast-enhanced sonography in the diagnosis of small hepatocellular carcinoma < or 02 cm J Clin Ultrasound 36 257-266
15. Xu HX, Liu GJ, Lu MD et al (2006) Characterization of small focal liver lesions using real-time contrast-enhanced sonography: diagnostic performance analysis in 200 patients. J Ultrasound Med 25:349-361
16. Soussan M, Aubé C, Bahrami S, Boursier J, Valla DC, Vilgrain V (2010) Incidental focal solid liver lesions: diagnostic performance of contrast-enhanced ultrasound and MR imaging. Eur Radiol 20:1715-1725
17. Wen YL, Kudo M, Zheng RQ et al (2004) Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio. AJR Am J Roentgenol 182:1019-1026 (Pubitemid 38391667)
18. Giorgio A, Ferraioli G, Tarantino L et al (2004) Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrhosis: comparison with contrast-enhanced helical CTappearance. AJR Am J Roentgenol 183:1319-1326 (Pubitemid 44210595)
19. KodaM,MatsunagaY, UekiMet al (2004) Qualitative assessment of tumor vascularity in hepatocellular carcinoma by contrast-enhanced coded ultrasound: comparison with arterial phase of dynamic CTand conventional color/power Doppler ultrasound. Eur Radiol 14:1100-1108 (Pubitemid 38787255)
20. Bolondi L, Gaiani S, Celli N et al (2005) Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 42:27-34 (Pubitemid 40911308)
21. International Working Party (1995) Terminology of nodular hepatocellular lesion. Hepatology 22:983-993
22. Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86:420-428
23. Sakamoto M, Hirohashi S (1998) Natural history and prognosis of adenomatous hyperplasia and early hepatocellular carcinoma: multiinstitutional analysis of 53 nodules followed up for more than 6 months and 142 patients with single early hepatocellular carcinoma treated by surgical resection or percutaneous ethanol injection. Jpn J Clin Oncol 28:604-608 (Pubitemid 128525800)
24. Nakashima Y, Nakashima O, Hsia C, Kojiro M, Tabor E (1999) Vascularization of small hepatocellular carcinoma: correlation with differentiation. Liver 19:12-18 (Pubitemid 29034105)
25. Matsui O, Kadoya M, Kameyama T et al (1989) Adenomatous hyperplastic nodules in the cirrhotic liver: differentiation from hepatocellular carcinoma with MR imaging. Radiology 173:1223-126
26. Hayashi M, Matsui O, Ueda K et al (1999) Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AJR Am J Roentgenol 172:969-976 (Pubitemid 29505622)
27. Hayashi M, Matsui O, Ueda K et al (2002) Progression to hypervascular hepatocellular carcinoma: Correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. Radiology 225:143-149
28. Di Martino M, Marin D, Guerrisi A et al (2010) Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64- section multidetector CT in the detection of hepatocellular carcinoma in patients with cirrhosis. Radiology 256:806-816
29. Ahn SS, Kim MJ, Lim JS et al (2010) Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma. Radiology 255:459-466
30. Yamashita Y, Mitsuzaki K, Yi T et al (1996) Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology 200:79-84 (Pubitemid 26197342)
31. Kumada T, Toyoda H, Tada T et al (2011) Evolution of hypointense hepatocellular nodules observed only in the hepatobiliary phase of gadoxetate disodium-enhancedMRI. AJRAmJ Roentgenol 197:58-63